சீனா சங்கம் ஆஃப் ஆரோக்கியம் ப்ரமோஶந் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சீனா சங்கம் ஆஃப் ஆரோக்கியம் ப்ரமோஶந். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சீனா சங்கம் ஆஃப் ஆரோக்கியம் ப்ரமோஶந் Today - Breaking & Trending Today

"The Buzz" Show: Zhongchao Inc. (NASDAQ: ZCMD) Renews Medical Education Contract | "The Buzz" Show: Zhongchao Inc. (NASDAQ: ZCMD) Renews Medical Education ContractFinancial Buzz


FinancialBuzz.com’s latest
The Buzz Show: Featuring Our Corporate News Recap on “Zhongchao Inc. Shares Rise After Renewing its Contract with China Association of Health Promotion and Education and GlaxoSmithKline”
Zhongchao Inc.
(NASDAQ: ZCMD) shot up just over 87% in premarket trading after the company renewed its partnership with the China Association for Health Promotion and Education and GlaxoSmithKline Investment Limited.
The partnership seeks to continue the medical education program “Pulmonary Arterial Hypertension Online Course – Connections with Famous Hospitals”, which aims to promote the implementation of the multidisciplinary treatment model of pulmonary hypertension and improve doctors’ ability to solve clinical problems. ....

China Association For Health Promotion , Zhongchao Inc , Glaxosmithkline Investment , China Association Of Health Promotion , Our Corporate News Recap On Zhongchao Inc , Buzz Show , Featuring Our Corporate News Recap , Shares Rise After Renewing , China Association , Health Promotion , Arterial Hypertension Online Course , Beijing China , சீனா சங்கம் க்கு ஆரோக்கியம் ப்ரமோஶந் , கிளாக்சோஸ்மித்க்லைன் முதலீடு , சீனா சங்கம் ஆஃப் ஆரோக்கியம் ப்ரமோஶந் , புழ்ழ் காட்டு , இடம்பெறும் அவர் பெருநிறுவன செய்தி ரீக்யாப் , சீனா சங்கம் , ஆரோக்கியம் ப்ரமோஶந் , தமனி உயர் இரத்த அழுத்தம் நிகழ்நிலை நிச்சயமாக , பெய்ஜிங் சீனா ,

Zhongchao Inc. Promotes Standardized Liver Cancer Diagnosis and Treatment with Medical Associations and Experts


Share this article
Share this article
SHANGHAI, Jan. 13, 2021 /PRNewswire/ Zhongchao Inc. (NASDAQ: ZCMD) ( Zhongchao or the Company ), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced that it co-sponsored the National Annual Conference for Standardized Liver Cancer Diagnosis and Treatment (the Annual Conference ) with China Association of Health Promotion and Education and Chinese Society of Liver Cancer.
In 2020, Zhongchao worked with medical associations and experts to jointly carry out a multi-year online education project on the diagnosis and treatment of primary liver cancer. This project aims to promote and implement the Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2019 Edition) (the Guidelines ) published by the National Health Commission of the People s Republic of China. Based on the professional interpretation and throug ....

Sherry Zheng , Weiguang Yang , Jia Fan , Pei Xu , Chinese Society Of Liver Cancer , Zhongshan Hospital At Fudan University , Zhongchao Inc , China Association Of Health Promotion , Weitian Group , Chinese Academy Of Sciences , Sunshine Health Forums , Prnewswire Zhongchao Inc , National Annual Conference , Standardized Liver Cancer Diagnosis , China Association , Health Promotion , Chinese Society , Primary Liver Cancer , National Health Commission , Annual Conference , Chinese Academy , Sciences Fellow , Zhongshan Hospital , Fudan University , General Supervisor , Chief Executive Officer ,

José M. Vega, M.D. Joins Moderna as Chief Safety Officer


José M. Vega, M.D. Joins Moderna as Chief Safety Officer
José M. Vega, M.D. Joins Moderna as Chief Safety Officer
Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Jos M. Vega, M.D. joined Moderna as Chief Safety Officer effective Monday, January 11, 2021. Dr. Vega will report to Chief Medical Officer Tal Zaks, M.D., Ph.D.
Jos brings a strategic level of leadership and deep experience in drug development and pharmacovigilance in global biopharmaceutical companies including Merck and Amgen, said Dr. Zaks. I am thrilled to welcome Jos to the Moderna team as we enter the next phase of growth of our company. ....

Sherry Zheng , Weiguang Yang , Jia Fan , Pei Xu , Chinese Society Of Liver Cancer , Zhongshan Hospital At Fudan University , Zhongchao Inc , China Association Of Health Promotion , Weitian Group , Chinese Academy Of Sciences , Sunshine Health Forums , National Annual Conference , Standardized Liver Cancer Diagnosis , China Association , Health Promotion , Chinese Society , Primary Liver Cancer , National Health Commission , Annual Conference , Chinese Academy , Sciences Fellow , Zhongshan Hospital , Fudan University , General Supervisor , Chief Executive Officer , Private Securities Litigation Reform Act ,